Labcorp Holdings Inc (NYSE:LH) reported better-than-expected second-quarter financial results and raised its FY24 revenue guidance above estimates on Thursday. Laboratory Corp reported second-quarter 2024 adjusted EPS of $3.94, up from $3.42 a year ago, beating the consensus of $3.78. Sales increased 6.2% year-over-year to $3.22 billion, beating the consensus of $3.19 billion. Diagnostics Laboratories revenue for the quarter was $2.52 billion, an increase of 7.9%. Biopharma Laboratory Services revenue increased 1.1% to $707.0 million. LabCorp slashed its 2024 adjusted EPS outlook from ...